| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 36.346.062 $ | 92,43 | 967.221 | |||||||
| Gilead Sciences Inc. | GILEAD SCIENCES | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 2.823.636 $ | 7,18 | 20.260 | |
| AstraZeneca PLC | ASTRAZENECA PLC | EC | G0593M107 | Long | Börsenkurs (Stufe 1) | 2.215.175 $ | 5,63 | 11.232 | |
| Vertex Pharmaceuticals Incorporated | VERTEX PHARM | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 2.201.889 $ | 5,60 | 4.931 | |
| Ionis Pharmaceuticals, Inc. | IONIS PHARMACEUT | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 1.470.788 $ | 3,74 | 19.587 | |
| Insmed Inc | INSMED INC | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 1.403.492 $ | 3,57 | 8.583 | |
| Incyte Corporation. | INCYTE CORP | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 1.340.739 $ | 3,41 | 14.245 | |
| Roivant Sciences Ltd | ROIVANT SCIENCES | EC | G76279101 | Long | Börsenkurs (Stufe 1) | 1.320.376 $ | 3,36 | 47.667 | |
| Argenx SE | ARGENX SE - ADR | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 1.310.069 $ | 3,33 | 1.794 | |
| Neurocrine Biosciences Inc | NEUROCRINE BIOSC | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 1.265.626 $ | 3,22 | 9.607 | |
| Axsome Therapeutics Inc. | AXSOME THERAPEUT | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 1.088.151 $ | 2,77 | 6.438 | |
| Ascendis Pharma A/S | ASCENDIS PHA-ADR | EC | 04351P101 | Long | Börsenkurs (Stufe 1) | 1.035.232 $ | 2,63 | 4.526 | |
| Apogee Therapeutics Inc. | APOGEE THERAPEUT | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 956.929 $ | 2,43 | 11.369 | |
| Protagonist Therapeutics Inc | PROTAGONIST THER | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 952.816 $ | 2,42 | 9.040 | |
| Amgen Inc. | AMGEN INC | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 819.459 $ | 2,08 | 2.329 | |
| Rhythm Pharmaceuticals Inc | RHYTHM PHARMACEU | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 808.560 $ | 2,06 | 9.297 | |
| AbbVie Inc. | ABBVIE INC | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 770.785 $ | 1,96 | 3.544 | |
| Biogen Inc | BIOGEN INC | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 703.071 $ | 1,79 | 3.835 | |
| Sanofi SA | SANOFI-ADR | EC | 80105N105 | Long | Börsenkurs (Stufe 1) | 692.925 $ | 1,76 | 14.382 | |
| Jazz Pharmaceuticals PLC | JAZZ PHARMACEUTI | EC | G50871105 | Long | Börsenkurs (Stufe 1) | 673.207 $ | 1,71 | 3.561 | |
| Catalyst Pharmaceuticals Inc. | CATALYST PHARMAC | EC | 14888U101 | Long | Börsenkurs (Stufe 1) | 576.561 $ | 1,47 | 23.286 | |
| Oruka Therapeutics Inc | ORUKA THERAPEUTI | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 564.369 $ | 1,44 | 11.506 | |
| BioNTech SE | BIONTECH SE-ADR | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 499.150 $ | 1,27 | 5.616 | |
| Krystal Biotech Inc | KRYSTAL BIOTECH | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 495.458 $ | 1,26 | 1.918 | |
| Edgewise Therapeutics Inc. | EDGEWISE THERAPE | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 491.873 $ | 1,25 | 15.615 | |
| Nuvalent Inc | NUVALENT INC-A | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 477.110 $ | 1,21 | 4.657 | |
| Agios Pharmaceuticals Inc | AGIOS PHARMACEUT | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 472.639 $ | 1,20 | 13.971 | |
| NewAmsterdam Pharma Company NV | NEWAMSTERDAM PHA | EC | N62509109 | Long | Börsenkurs (Stufe 1) | 469.139 $ | 1,19 | 14.656 | |
| MeiraGTx Holdings PLC | MEIRAGTX HOLDING | EC | G59665102 | Long | Börsenkurs (Stufe 1) | 464.990 $ | 1,18 | 53.694 | |
| Alnylam Pharmaceuticals Inc. | ALNYLAM PHARMACE | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 453.292 $ | 1,15 | 1.370 | |
| Kymera Therapeutics Inc | KYMERA THERAPEUT | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 444.935 $ | 1,13 | 5.342 | |
| Personalis Inc | PERSONALIS INC | EC | 71535D106 | Long | Börsenkurs (Stufe 1) | 407.884 $ | 1,04 | 64.032 | |
| Celldex Therapeutics Inc. | CELLDEX THERAPEU | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 400.116 $ | 1,02 | 12.614 | |
| Nurix Therapeutics Inc. | NURIX THERAPEUTI | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 396.351 $ | 1,01 | 25.571 | |
| Abivax SA | ABIVAX SA-ADR | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 381.262 $ | 0,97 | 3.424 | |
| Cytokinetics Inc | CYTOKINETICS INC | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 370.151 $ | 0,94 | 5.616 | |
| Spyre Therapeutics Inc | SPYRE THERAPEUTI | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 334.619 $ | 0,85 | 6.634 | |
| Halozyme Therapeutics Inc | HALOZYME THERAPE | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 309.836 $ | 0,79 | 4.794 | |
| Cullinan Therapeutics Inc | CULLINAN THERAPE | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 286.118 $ | 0,73 | 20.135 | |
| Trevi Therapeutics Inc | TREVI THERAPEUTI | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 285.962 $ | 0,73 | 23.970 | |
| Natera Inc. | NATERA INC | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 273.986 $ | 0,70 | 1.370 | |
| Xeris Biopharma Holdings Inc | XERIS BIOPHARMA | EC | 98422E103 | Long | Börsenkurs (Stufe 1) | 266.139 $ | 0,68 | 45.886 | |
| Disc Medicine Inc | DISC MEDICINE IN | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 253.970 $ | 0,65 | 3.972 | |
| Design Therapeutics Inc. | DESIGN THERAPEUT | EC | 25056L103 | Long | Börsenkurs (Stufe 1) | 225.898 $ | 0,57 | 21.231 | |
| Veracyte Inc | VERACYTE INC | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 220.252 $ | 0,56 | 6.838 | |
| Rezolute Inc | REZOLUTE INC | EC | 76200L309 | Long | Börsenkurs (Stufe 1) | 217.242 $ | 0,55 | 71.227 | |
| Tectonic Therapeutic Inc | TECTONIC THERAPE | EC | 878972108 | Long | Börsenkurs (Stufe 1) | 211.703 $ | 0,54 | 6.849 | |
| Wave Life Sciences Ltd. | WAVE LIFE SCIENC | EC | Y95308105 | Long | Börsenkurs (Stufe 1) | 211.519 $ | 0,54 | 29.175 | |
| Monte Rosa Therapeutics Inc | MONTE ROSA THERA | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 206.711 $ | 0,53 | 12.566 | |
| Rapport Therapeutics Inc | RAPPORT THERAPEU | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 201.445 $ | 0,51 | 6.438 | |
| Sionna Therapeutics Inc. | SIONNA THERAPEUT | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 193.154 $ | 0,49 | 4.818 | |
| Candel Therapeutics Inc | CANDEL THERAPEUT | EC | 137404109 | Long | Börsenkurs (Stufe 1) | 177.934 $ | 0,45 | 36.313 | |
| Atrium Therapeutics Inc. | ATRIUM THERAPEUT | EC | 04965N104 | Long | Börsenkurs (Stufe 1) | 177.634 $ | 0,45 | 13.286 | |
| Avalo Therapeutics Inc | AVALO THERAPEUTI | EC | 05338F306 | Long | Börsenkurs (Stufe 1) | 174.203 $ | 0,44 | 11.668 | |
| Intellia Therapeutics Inc | INTELLIA THERAPE | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 147.507 $ | 0,38 | 11.506 | |
| IQVIA Holdings Inc. | IQVIA HOLDINGS I | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 140.184 $ | 0,36 | 822 | |
| Arvinas Inc | ARVINAS INC | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 139.390 $ | 0,35 | 13.150 | |
| Annexon Inc | ANNEXON INC | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 135.830 $ | 0,35 | 24.518 | |
| Icon PLC | ICON PLC | EC | G4705A100 | Long | Börsenkurs (Stufe 1) | 107.672 $ | 0,27 | 973 | |
| Adma Biologics Inc | ADMA BIOLOGICS I | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 90.433 $ | 0,23 | 10.037 | |
| MDXHealth SA | MDXHEALTH | EC | B5950S113 | Long | Börsenkurs (Stufe 1) | 75.787 $ | 0,19 | 32.951 | |
| Aldeyra Therapeutics Inc. | ALDEYRA THERAPEU | EC | 01438T106 | Long | Börsenkurs (Stufe 1) | 62.733 $ | 0,16 | 37.120 | |
| Alkermes PLC | ALKERMES PLC CVR | EC | Long | Modellwert (Stufe 2) | beschränkt | 0 $ | 0,00 | 39.859 | |
| 36.346.062 $ | 92,43 | 967.221 |